Overexpression of CD97 in intestinal epithelial cells of transgenic mice attenuates colitis by strengthening adherens junctions

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Becker, Susann ^a   Wandel, Elke ^a   Wobus, Manja ^a   Schneider, Rick ^a   Amasheh, Salah ^b   Sittig, Doreen ^a   Kerner, Christiane ^a   Naumann, Ronald ^c   Hamann, Joerg ^d   Aust, Gabriela ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN; CD97 ANTIGEN; COMPLEMENTARY DNA; DEXTRAN SULFATE; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; UVOMORULIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL JUNCTION; COLITIS; COLORECTAL CARCINOMA; EPITHELIUM CELL; INTESTINE CELL; MOUSE; NONHUMAN; TIGHT JUNCTION; TRANSGENIC MOUSE;

ADHERENS JUNCTIONS; ANIMALS; BASE SEQUENCE; BETA CATENIN; COLITIS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOGEN SYNTHASE KINASE 3; INTESTINAL MUCOSA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

MURINAE; MUS; MUS MUSCULUS;

EID: 77649255287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008507     Document Type: Article

References (36)

1. Niessen CM, Gottardi CJ (2008) Molecular components of the adherens junction. Biochim Biophys Acta 1778: 562-571.
2. Kam Y, Quaranta V (2009) Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PLoS ONE 4: e4580.
3. Jeanes A, Gottardi CJ, Yap AS (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27: 6920-6929.
4. Ivanov AI, McCall IC, Parkos CA, Nusrat A (2004) Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex. Mol Biol Cell 15: 2639-2651.
5. Zbar AP, Simopoulos C, Karayiannakis AJ (2004) Cadherins: an integral role in inflammatory bowel disease and mucosal restitution. J Gastroenterol 39: 413-421.
6. Bruewer M, Samarin S, Nusrat A (2006) Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 1072: 242-252.
7. Abe K, Takeichi M (2008) EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt. Proc Natl Acad Sci U S A 105: 13-19.
8. Rivard N (2009) Phosphatidylinositol 3-kinase: a key regulator in adherens junction formation and function. Front Biosci 14: 510-22. 510-522.
9. Yona S, Lin HH, Siu WO, Gordon S, Stacey M (2008) Adhesion-GPCRs: emerging roles for novel receptors. Trends Biochem Sci 33: 491-500.
10. Steinert M, Wobus M, Boltze C, Schütz A, Wahlbuhl M, et al. (2002) Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am J Pathol 161: 1657-1667.
11. Galle J, Sittig D, Hanisch I, Wobus M, Wandel E, et al. (2006) Individual cell - based models of tumor - environment interactions. Multiple effects of CD97 on tumor invasion. Am J Pathol 169: 1802-1811.
12. Pinto D, Robine S, Jaisser F, El Marjou FE, Louvard D (1999) Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J Biol Chem 274: 6476-6482.
13. Hamann J, van Zeventer C, Bijl A, Molenaar C, Tesselaar K, et al. (2000) Molecular cloning and characterization of mouse CD97. Int Immunol 12: 439-448.
14. Veninga H, Becker S, Hoek RM, Wobus M, Wandel E, et al. (2008) Analysis of CD97 expression and manipulation: antibody treatment but not gene targeting curtails granulocyte migration. J Immunol 181: 6574-6583.
15. Cooper HS, Murthy SN, Shah RS, Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249.
16. Fitzpatrick LR, Khare V, Small JS, Koltun WA (2006) Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout mice. Dig Dis Sci 51: 1269-1276.
17. Schulzke JD, Gitter AH, Mankertz J, Spiegel S, Seidler U, et al. (2005) Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta 1669: 34-42.
18. Kreusel KM, Fromm M, Schulzke JD, Hegel U (1991) Cl- secretion in epithelial monolayers of mucus-forming human colon cells (HT-29/B6). Am J Physiol 261: 574-582.
19. Pelech S, Jelinkova L, Susor A, Zhang H, Shi X, et al. (2008) Antibody microarray analyses of signal transduction protein expression and phosphorylation during porcine oocyte maturation. J Proteome Res 7: 2860-2871.
20. Horvat B, Osborn M, Damjanov I (1990) Expression of villin in the mouse oviduct and the seminiferous ducts. Histochemistry 93: 661-663.
21. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997) beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
22. Yost C, Torres M, Miller JR, Huang E, Kimelman D, et al. (1996) The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 10: 1443-1454.
23. Srivastava AK, Pandey SK (1998) Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol Cell Biochem 182: 135-141.
24. Kitajima S, Takuma S, Morimoto M (1999) Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim 48: 137-143.
25. Neufert C, Becker C, Neurath MF (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2: 1998-2004.
26. Faux MC, Ross JL, Meeker C, Johns T, Ji H, et al. (2004) Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J Cell Sci 117: 427-439.
27. Wong NA, Pignatelli M (2002) Beta-catenin-a linchpin in colorectal carcino-genesis? Am J Pathol 160: 389-401.
28. Aust G, Sittig D, Wandel E, Wobus M, Galle J (2007) Der Zelloberflächenrezeptor CD97 stimuliert die Migration von Tumorzellen durch Interaktion mit dem Aktin-Zytoskelett. Chirurgisches Forum 36: 81-82.
29. Eichler W, Aust G, Hamann D (1994) Characterization of the early activation-dependent antigen on lymphocytes defined by the monoclonal antibody BL-Ac(F2). Scand J Immunol 39: 111-115.
30. Leemans JC, te Velde AA, Florquin S, Bennink RJ, de Bruin K, et al. (2004) The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J Immunol 172: 1125-1131.
31. Aust G, Eichler W, Laue S, Lehmann I, Heldin N-E, et al. (1997) CD97: A dedifferentiation marker in human thyroid carcinomas. Cancer Res 57: 1798-1806.
32. Johnson M, Sharma M, Jamieson C, Henderson JM, Mok MT, et al. (2009) Regulation of beta-catenin trafficking to the membrane in living cells. Cell Signal 21: 339-348.
33. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, et al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 66: 1863-1870.
34. Mathew CG, Lewis CM (2004) Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 13: 161-168.
35. Zhang L, Yang X, Cummings F, McGovern D, Jewell D (2004) Polymorphisms in the genes of epidermal growth factor module-containing mucin-like hormone recpetor 1, 2,3 (EMR1, 2, 3) and CD97 in association with inflammatory bowel disease (IBD). Human Genome Meeting 2004 (HGM 2004), abstract.
36. Kwakkenbos MJ, van Lier RA, Hamann J (2002) Characterization of EGF-TM7 family members by novel monoclonal antibodies. In: Mason D, editors. Leucocyte Typing VII. White Cell Differentiation Antigens. Oxford: Oxford University Press. pp 381-383.